Myriad Genetics
MYGN
MYGN
198 hedge funds and large institutions have $1.45B invested in Myriad Genetics in 2022 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 72 increasing their positions, 65 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
3% less funds holding
Funds holding: 205 → 198 (-7)
27% less capital invested
Capital invested by funds: $1.98B → $1.45B (-$530M)
Holders
198
Holding in Top 10
–
Calls
$4.9M
Puts
$897K
Top Buyers
| 1 | +$27.3M | |
| 2 | +$19.3M | |
| 3 | +$11M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$7.02M |
| 5 |
SEI Investments
Oaks,
Pennsylvania
|
+$5.27M |
Top Sellers
| 1 | -$12.8M | |
| 2 | -$8.92M | |
| 3 | -$8.69M | |
| 4 |
Man Group
London,
United Kingdom
|
-$6.86M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$5.2M |